RCS - Cambridge Cognition - Investor Presentation via Investor Meet Company

Cambridge Cognition HoldingsAnnouncement

Yesterday 11:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250901:nRSA4620Xa&default-theme=true

RNS Number : 4620X  Cambridge Cognition Holdings PLC  01 September 2025

 

01 September 2025

Cambridge Cognition Holdings plc

("Cambridge Cognition", the "Company" or the "Group")

Investor Presentation via Investor Meet Company

 

Cambridge Cognition Holdings plc (AIM: COG), the brain health software group
specialising in digital health products that advance brain health research and
treatment, is pleased to announce that Rob Baker (Group Chief Operating
Officer and Senior Executive Director) and Ronald Openshaw (Chief Financial
Officer and Head of Corporate Development) will provide a live presentation
relating to the Interim Results via Investor Meet Company on 03 September
2025, 11:00 BST.

The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
02 September 2025, 09:00 BST, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet
Cambridge Cognition Holdings plc via:

https://www.investormeetcompany.com/cambridge-cognition-holdings-plc/register-investor
(https://www.investormeetcompany.com/cambridge-cognition-holdings-plc/register-investor)

Investors who already follow Cambridge Cognition Holdings plc on the Investor
Meet Company platform will automatically be invited.

 

Enquiries:

 

 Cambridge Cognition Holdings plc                  Tel: 012 2381 0700 

 Rob Baker, Group Chief Operating Officer and      press@camcog.com (mailto:press@camcog.com)  

 Senior Executive Director

 Panmure Liberum Limited (NOMAD and Joint Broker)  Tel: 020 7886 2968

 Will Goode / Freddy Crossley / Mark Rogers        (Corporate Finance)

 Rupert Dearden                                    (Corporate Broking)

 Dowgate Capital Limited (Joint Broker)            Tel: 020 3903 7715 

 David Poutney / Amber Higgs                        

 

Notes to Editors

 

About Cambridge Cognition

 

Cambridge Cognition is a brain health software group specialising in digital
health products that advance brain health research and treatment.

Built on rich, curated data and deep technical expertise we are building a
strong global brand with scalable technology that will support the rising
world demand for diagnosing and treating brain health. The Company creates
shareholder value through organic sales growth, strategic partnerships, joint
ventures, and spinouts.  The Company has identified four market sectors:

·    Clinical Studies for new pharmaceuticals;

·    Academic Research for scientists to understand CNS disorders;

·    Healthcare to provide physicians with cognitive assessments to allow
them to diagnose and treat patients; and,

·    Consumer Health & Wellness to provide individuals access to
accurate, reliable, and meaningful data to assess their cognitive health.

For further information, visit: www.cambridgecognition.com
(http://www.cambridgecognition.com/)

 

END

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAGCGDCIUGDGUB